NLC India declares Q1 FY 2026-27 results, appoints tax auditor for FY 2025-26
NLC India · Power
Key highlights
- Board approved standalone and consolidated unaudited financial results for the quarter ended June 30, 2026
- Secured NCDs of ₹1,475 crore and ₹525 crore, and unsecured NCDs of ₹500 crore; auditors certify all covenants complied with
- Appointed M/s. Sundaram & Srinivasan as Tax Auditor for FY 2025-26; firm established 1943 with 15 partners
Why it's rated major development: the year-on-year change is 48% (20% or more for adverse news)
Figures checked against the filing by a second AI read, which corrected the first summary. About the business, not the share price.
Original filing
Board Meeting Outcome for Outcome Of Board Meeting
Read the filing on BSE (PDF) →Companies guiding to strong growth
Ranked by management's own guidance on revenue and margins — not by us.
Aerospace & Defense
Sign up free to see all 6 →
See full rankingsRank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
More from NLC India
- Financial resultsMajor developmentNLC India Limited approves Q2 and half-year results, 15% interim dividend and bond plan
- Dividend / buyback / bonusMajor developmentNLC India Limited announces Q2 FY2026-27 results, interim dividend, and bond issue
- Dividend / buyback / bonusMajor developmentNLC India Limited announces Q2 FY27 financial results, interim dividend, and bond issue
- Order winNotableNLC India Renewables wins 200 MW wind power project from SJVN Limited
- Acquisition / mergerNotableNLC India Limited forms JV with NALCO for 1,080 MW thermal power plant in Odisha
Other capex / expansion filings this fortnight
- Maharaja & Speedex India Limited raises manufacturing capacity to 72 lakh units/year
- Elin Electronics Q2 FY27 earnings report with 10% revenue growth and margin update
- HOAC Foods India Limited H1 FY27 Earnings Call Transcript dated November 5, 2026
- Gujarat State Fertilizers & Chemicals Limited Q2 FY27 Earnings Call Highlights
- Supriya Lifescience H1 revenue up 14.8% to ₹396.04 crore; Q2 profit falls
- V-MARC India Ltd announces Q2 & H1 FY27 unaudited financial results and review report
Potential multibaggers · Q2 FY27
Potential multibaggers in Power
on management's own guidance
- Strong growth2
- Strong growth1
- Adani PowerGood growth3
Portfolio builder
Build your portfolio
from the top-ranked stocks
- 1. Pick 3–15 stocks
- 2. Choose large, mid or small cap and your sectors
- 3. Get a portfolio built from the rankings
Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.
Summary written by Arthneeti from the company's filing with the stock exchange; check the original filing for full details. Arthneeti is a research and analytics platform, not a SEBI-registered investment adviser, and nothing here is a recommendation to buy or sell.